Associations between arsenic species in exfoliated urothelial cells and prevalence of diabetes among residents of chihuahua, Mexico

Environmental Health Perspectives

Volumn 122, Issue 10, 2014, Pages 1088-1094

  Currier, Jenna M ^a   Ishida, MaríA C ^b   González Horta, Carmen ^b   Sánchez Ramírez, Blanca ^b   Ballinas Casarrubias, Lourdes ^b   Gutiérrez Torres, Daniela S ^b   Cerón, Roberto HernáNdez ^c   Morales, DamiáN Viniegra ^c   Baeza Terrazas, Francisco A ^c   Del Razo, Luz M ^d   García Vargas, Gonzalo G ^e   Jesse Saunders, R ^f   Drobná, Zuzana ^f   Matoušek, Tomáš ^g,h   Buse, John B ⁱ   Mendez, Michelle A ^a,f,j   Loomis, Dana ^k   Stýblo, Miroslav ^a,f  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSIDAD AUTÓNOMA DE CHIHUAHUA   (Mexico)

^c Centro de InvestigaciCentro de InvestigaciCentro de Investigación y de Estudios ^*  (Mexico)

^d DEPARTAMENTO DE FÍSICA   (Mexico)

^e UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^f Department of Nutrition ^*  (Mexico)

^g University of North Carolina at Chapel Hill   (United States)

^h INSTITUTE OF ANALYTICAL CHEMISTRY   (Czech Republic)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL   (United States)

^k INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; ARSENIC ACID; ARSENIC DERIVATIVE; ARSENIC TRIOXIDE; CACODYLIC ACID; CREATININE; METHANEARSONIC ACID; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; ORGANOARSENIC DERIVATIVE; WATER POLLUTANT;

ADULT; ARSENIC POISONING; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG URINE LEVEL; ENVIRONMENTAL EXPOSURE; EXFOLIATED UROTHELIAL CELL; FEMALE; HOUSEHOLD; HUMAN; HUMAN CELL; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; RELATIVE DENSITY; RESIDENT; SEX DIFFERENCE; URINE; UROTHELIUM; ADVERSE EFFECTS; ANALYSIS; CHEMICALLY INDUCED; CHEMISTRY; EPITHELIUM CELL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; METABOLISM; MEXICO; MIDDLE AGED; PREVALENCE; STATISTICS AND NUMERICAL DATA; WATER POLLUTANT; WATER SUPPLY;

ADULT; ARSENIC; ARSENIC POISONING; ARSENICALS; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; EPITHELIAL CELLS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MEXICO; MIDDLE AGED; PREVALENCE; UROTHELIUM; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 84907662202     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1307756     Document Type: Article

References (30)

1. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. 2005. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 113:192–200; doi:10.1289/ehp.7337.
2. Boeniger MF, Lowry LK, Rosenberg J. 1993. Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am Ind Hyg Assoc J 54:615–627.
3. Chadha V, Garg U, Alon US. 2001. Measurement of urinary concentration: a critical appraisal of methodologies. Pediatr Nephrol 16:374–382.
4. Currier JM, Svoboda M, de Moraes DP, Matoušek T, Dědina J, Stýblo M. 2011a. Direct analysis of methylated trivalent arsenicals in mouse liver by hydride generation-cryotrapping- atomic absorption spectrometry. Chem Res Toxicol 24:478–480.
5. Currier JM, Svoboda M, Matoušek T, Dědina J, Stýblo M. 2011b. Direct analysis and stability of methylated trivalent arsenic metabolites in cells and tissues. Metallomics 3:1347–1354.
6. Del Razo M, García-Vargas GG, Valenzuela OL, Hernandez- Castellanos E, Sánchez-Peňa LC, Drobná Z, et al. 2011. Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapan and Lagunera regions in Mexico. Environ Health 10:73; doi:10.1186/1476-069X-10-73.
7. Dodmane PR, Arnold LL, Muirhead DE, Suzuki S, Yokohira M, Pennington KL, et al. 2014. Characterization of intracellular inclusions in the urothelium of mice exposed to inorganic arsenic. Toxicol Sci 137:36–46.
8. Douillet C, Currier J, Saunders RJ, Bodnar WM, Matoušek T, Stýblo M. 2013. Methylated trivalent arsenicals are potent inhibitors of glucose stimulated insulin secretion by murine pancreatic islets. Toxicol Appl Pharmacol 267:11–15.
9. Fortin F, Anghel T, Brochu P, Lemieux N. 2010. Optimizing urothelial cell preparation for the human urinary micronucleus assay. Toxicol In Vitro 24:1821–1827.
10. Fu J, Woods CG, Yehuda-Shnaidman E, Zhang Q, Wong V, Collins S, et al. 2010. Low-level arsenic impairs glucosestimulated insulin secretion in pancreatic beta cells: involvement of cellular adaptive response to oxidative stress. Environ Health Perspect 118:864–870; doi:10.1289/ ehp.0901608.
11. Gong ZL, Lu XF, Cullen WR, Le XC. 2001. Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid. J Anal At Spectrom 16:1409–1413.
12. Gribble MO, Howard BV, Umans JG, Shara NM, Francesconi KA, Goessler W, et al. 2012. Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study. Am J Epidemiol 176:865–874.
13. Hernández-Zavala A, Matoušek T, Drobna Z, Paul DS, Walton F, Adair BM, et al. 2008a. Speciation analysis of arsenic in biological matrices by automated hydride generationcryotrapping- atomic absorption spectrometry with multiple microflame quartz tube atomizer (multiatomizer). J Anal At Spectrom 23:342–351.
14. Hernández-Zavala A, Valenzuela OL, Matoušek T, Drobna Z, Dědina J, Garcia-Vargas GG, et al. 2008b. Speciation of arsenic in exfoliated urinary bladder epithelial cells from individuals exposed to arsenic in drinking water. Environ Health Perspect 116:1656–1660; doi:10.1289/ehp.11503.
15. James KA, Marshall JA, Hokanson JE, Meliker JR, Zerbe GO, Byers TE. 2013. A case-cohort study examining lifetime exposure to inorganic arsenic in drinking water and diabetes mellitus. Environ Res 123:33–38.
16. Jerums G, Premaratne E, Panagiotopoulos S, Macisaac RJ. 2010. The clinical significance of hyperfiltration in diabetes. Diabetologia 53:2093–2104.
17. Kim NH, Mason CC, Nelson RG, Afton SE, Essader AS, Medlin JE, et al. 2013. Arsenic exposure and incidence of type 2 diabetes in southwestern American Indians. Am J Epidemiol 177:962–969.
18. Kuo CC, Moon K, Thayer KA, Navas-Acien A. 2013. Environmental chemicals and type 2 diabetes: an updated systematic review of the epidemiologic evidence. Curr Diab Rep 13:831–849.
19. Mahalingaiah S, Meeker JD, Pearson KR, Calafat AM, Ye X, Petrozza J, et al. 2008. Temporal variability and predictors of urinary bisphenol A concentrations in men and women. Environ Health Perspect 116:173–178; doi:10.1289/ehp.10605.
20. Matoušek T, Currier JM, Trojánková N, Saunders RJ, Ishida MC, González-Horta C, et al. 2013. Selective hydride generationcryotrapping- ICP-MS for arsenic speciation analysis at picogram levels: analysis of river and sea water reference materials and human bladder epithelial cells. J Anal At Spectrom 28:1456–1465.
21. Maull EA, Ahsan H, Edwards J, Longnecker MP, Navas-Acien A, Pi J, et al. 2012. Evaluation of the association between arsenic and diabetes: a National Toxicology Program Workshop Review. Environ Health Perspect 120:1658–1670; doi:10.1289/ehp.1104579.
22. Nermell B, Lindberg AL, Rahman M, Berglund M, Persson LA, El Arifeen S, et al. 2008. Urinary arsenic concentration adjustment factors and malnutrition. Environ Res 106:212–218.
23. Pan WC, Seow WJ, Kile ML, Hoffman EB, Quamruzzaman Q, Rahman M, et al. 2013. Association of low to moderate levels of arsenic exposure with risk of type 2 diabetes in Bangladesh. Am J Epidemiol 178:1563–1570.
24. Paul DS, Devesa V, Hernández-Zavala A, Adair BM, Walton FS, Drobna B, et al. 2008. Environmental arsenic as a disruptor of insulin signaling. In: Metal Ions in Biology and Medicine, Vol 10 (Collery PH, Maynard I, Theophanides T, Khassanova L, Callery T, Libbey J, eds). Paris:Eurotext, 1–7.
25. Paul DS, Harmon AW, Devesa V, Thomas DJ, Stýblo M. 2007. Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid. Environ Health Perspect 115:734–742; doi:10.1289/ehp.9867.
26. Tseng CH. 2007. Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 25:1–22.
27. Tyler DE. 1962. Stratified squamous epithelium in vesical trigone and urethra—findings correlated with menstrual cycle and age. Am J Anat 111:319–335.
28. Voinescu GC, Shoemaker M, Moore H, Khanna R, Nolph KD. 2002. The relationship between urine osmolality and specific gravity. Am J Med Sci 323:39–42.
29. Wang W, Xie Z, Lin Y, Zhang D. 2014. Association of inorganic arsenic exposure with type 2 diabetes mellitus: a metaanalysis. J Epidemiol Community Health 68:176–184.
30. Wedel WR, Muirhead DE, Arnold LL, Dodmane PR, Lele SM, Maness-Harris L, et al. 2013. Urothelial cell intracytoplasmic inclusions after treatment of promyelocytic leukemia with arsenic trioxide. Toxicol Sci 134:271–275. s